Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Henrik H Rossing"'
Autor:
Finn Cilius Nielsen, Jonas Vikesaa, Thomas Hansen, Henrik H Rossing, Sine Buhl, Vera Timmermans-Wielenga
Publikováno v:
BMC Cancer
Background Human epidermal growth factor receptor-2 (HER2) overexpression and gene amplification are currently established by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), respectively. This study investigates whether high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49aaf97c04a3896720b55d9f3545d8f6
https://doi.org/10.1186/s12885-015-1035-1
https://doi.org/10.1186/s12885-015-1035-1
Autor:
Lene Dissing Sjö, Jan Ulrik Prause, Volkert Siersma, Elisabeth Ralfkiaer, Steffen Heegaard, Lena Specht, Henrik H. Rossing, Peter Kristian Rasmussen
Publikováno v:
Acta ophthalmologica. 93(2)
Purpose To characterize the clinicopathological features of follicular lymphoma of the ocular adnexal region. Methods Retrospective nation-based study of Danish patients with ocular adnexal follicular lymphoma from January 1st 1980 through December 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cc81c5b5bc284735b9c5b453fbc9a5
https://pubmed.ncbi.nlm.nih.gov/25125069
https://pubmed.ncbi.nlm.nih.gov/25125069
Autor:
Linea Melchior, Eric Santoni-Rugiu, Junia Costa, Morten Grauslund, Birgit Guldhammer Skov, Henrik H Rossing, E. Urbanska, Jens Benn Sørensen, Charlotte K Rask
Publikováno v:
BMC Research Notes
Background Anaplastic lymphoma kinase-positive non-small cell lung carcinoma patients are generally highly responsive to the dual anaplastic lymphoma kinase and MET tyrosine kinase inhibitor crizotinib. However, they eventually acquire resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ba7c32cccf2785a4b28be7a45ed938
https://pubmed.ncbi.nlm.nih.gov/24279718
https://pubmed.ncbi.nlm.nih.gov/24279718
Autor:
Henrik H Rossing, Jens Vilstrup Johansen, Elisabeth Ralfkiaer, Eric Santoni-Rugiu, Ronald Simon, Mette Rose Jørgensen, Kristian Helin, Guido Sauter, Heidi Rye Hudlebusch
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 17(9)
Purpose: Multiple myeloma SET (Suppressor of variegation, Enhancer of zeste, and Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup of multiple myelomas with the t(4;14)(p16;q32) translocation and poor prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d85a27dd12f2fd68b0a8721c4b5778
https://pubmed.ncbi.nlm.nih.gov/21385930
https://pubmed.ncbi.nlm.nih.gov/21385930